PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
4.580
+0.050 (1.10%)
Nov 20, 2024, 4:00 PM EST - Market closed
PetMed Express Revenue
PetMed Express had revenue of $59.57M in the quarter ending September 30, 2024, a decrease of -16.10%. This brings the company's revenue in the last twelve months to $259.34M, down -4.08% year-over-year. In the fiscal year ending March 31, 2024, PetMed Express had annual revenue of $281.06M with 9.54% growth.
Revenue (ttm)
$259.34M
Revenue Growth
-4.08%
P/S Ratio
0.36
Revenue / Employee
$903,634
Employees
287
Market Cap
94.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 281.06M | 24.49M | 9.54% |
| Mar 31, 2023 | 256.58M | -15.70M | -5.77% |
| Mar 31, 2022 | 272.28M | -31.30M | -10.31% |
| Mar 31, 2021 | 303.58M | 19.46M | 6.85% |
| Mar 31, 2020 | 284.13M | 706.00K | 0.25% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Coherus BioSciences | 304.34M |
| So-Young International | 206.62M |
| Harvard Bioscience | 97.73M |
| Coya Therapeutics | 9.55M |
| Genelux | 8.00K |
PETS News
- 7 days ago - PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner - Business Wire
- 9 days ago - PetMed Express: Why (And Why Not) The Rebound Could Continue - Seeking Alpha
- 14 days ago - PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - PetMeds® Announces Second Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - PetMed Express, Inc. (PETS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer - GlobeNewsWire